单极经尿道前列腺腺瘤剜除术:初步报告
本研究前瞻性纳入47例接受单极经尿道前列腺腺瘤剜除术(mTUEPA)的男性患者,评估症状、尿流率和残余尿。术后IPSS从基线15.2±3.9降至4周时5.3±3,6个月和12个月Qmax分别为23.4±10.6 mL/s和18.8±9.2 mL/s(P<.001)。结论认为mTUEPA安全有效。
要点
- mTUEPA术后4周IPSS由基线15.2±3.9降至5.3±3,并在6和12个月维持。
- 术后6和12个月平均Qmax分别为23.4±10.6 mL/s和18.8±9.2 mL/s(P<.001)。
- 47例中13例(27.6%)报告14例次术后并发症,多为Clavien-Dindo I-II级。
核心结论
- mTUEPA是安全有效的技术,融合了激光剜除的原理与机械剜除的优势,并使用标准单极经尿道前列腺电切设备。
研究设计与样本
- 前瞻性连续纳入接受mTUEPA的男性患者,mTUEPA为使用标准单极电切镜逆行剜除前列腺腺瘤。
- 共纳入47例患者,术前平均前列腺体积为64.9±28.5 g,术前经直肠超声评估前列腺体积。
- 在基线及术后1、6、12个月评估症状、尿流率参数和排尿后残余尿。
- 抗血小板和抗凝药物在术前至少停用1周。
主要发现
- 基线平均总国际前列腺症状评分(IPSS)为15.2±3.9,峰值尿流率(Qmax)为8.4±2.9 mL/s,排尿后残余尿为103.2±90.6 mL。
- 术后4周患者报告平均IPSS为5.3±3,下尿路症状缓解在术后6和12个月进一步维持。
- 术后尿流率参数显著改善,术后6和12个月平均Qmax分别为23.4±10.6 mL/s和18.8±9.2 mL/s(P<.001)。
- 47例中13例(27.6%)报告14例次术后并发症,多数为轻微并发症(Clavien-Dindo I-II级)。
- 1例患者术中发生包膜穿孔,需要中断手术并进一步完成(Clavien-Dindo IIIb级)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe preliminary results of our monopolar transurethral enucleation of prostatic adenoma (mTUEPA). MATERIALS AND METHODS: A consecutive series of male patients treated with mTUEPA, a retrograde enucleation of the prostatic adenoma performed by means of a standard monopolar resectoscope, were prospectively enrolled. Symptoms, uroflowmetry parameters, and post-voiding residual were assessed at baseline and at 1, 6, and 12 months postoperatively. Prostate volume was evaluated at baseline by means of transrectal ultrasound. Antiplatelet and anticoagulant drugs were stopped at least 1 week before the operation. RESULTS: Forty-seven patients were enrolled. Mean preoperative prostate volume was 64.9 ± 28.5 g. When assessed at baseline, the mean total International Prostatic Symptoms Score was 15.2 ± 3.9, peak flow rate (Qmax) was 8.4 ± 2.9 mL/s and the post-voiding residual was 103.2 ± 90.6 mL. Four weeks after surgery, patients reported a mean International Prostatic Symptoms Score of 5.3 ± 3. This lower urinary tract symptoms relief was further maintained at 6 and 12 months after surgery. A significant postoperative improvement in uroflowmetry parameters was described, being the 6 and 12 months mean Qmax of 23.4 ± 10.6 mL/s and 18.8 ± 9.2 mL/s, respectively (P < .001). Overall, 14 postoperative complications were reported by 13 of 47 (27.6%) patients: most of them were minor complications (Clavien-Dindo Grade I-II), whereas 1 patient reported capsule perforation during surgery, requiring interruption of the procedure and its further completion (Clavien-Dindo IIIb). CONCLUSION: mTUEPA is a safe and effective technique, merging the principles of laser enucleation and the advantages of mechanical enucleation with standard monopolar transurethral resection of the prostate equipment.
引用
- Pansadoro V, Emiliozzi P, Del Vecchio G, et al. Monopolar Transurethral Enucleation of Prostatic Adenoma: Preliminary Report. Urology. 2017. PMID: 28087281. doi:10.1016/j.urology.2016.12.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。